Do-Youn, O., Aiwu Ruth, H., Shukui, Q., Li-Tzong, C., Takuji, O., Arndt, V., . . . Juan W, V. (2023). Plain language summary of the TOPAZ-1 study: Durvalumab and chemotherapy for advanced biliary tract cancer. Future Oncology, 19(34), 2277-2289. https://doi.org/10.2217/fon-2023-0468
Chicago Style (17th ed.) CitationDo-Youn, Oh, et al. "Plain Language Summary of the TOPAZ-1 Study: Durvalumab and Chemotherapy for Advanced Biliary Tract Cancer." Future Oncology 19, no. 34 (2023): 2277-2289. https://doi.org/10.2217/fon-2023-0468.
MLA (9th ed.) CitationDo-Youn, Oh, et al. "Plain Language Summary of the TOPAZ-1 Study: Durvalumab and Chemotherapy for Advanced Biliary Tract Cancer." Future Oncology, vol. 19, no. 34, 2023, pp. 2277-2289, https://doi.org/10.2217/fon-2023-0468.